TGFB1 and neoplasm: Following the study design depicted in Fig. 7e, mice were treated in vivo with isotype control antibodies, anti-TGFβ, anti-PD1, or a combination of the two, and were monitored for body weight changes (Supplementary Fig. 9b) and tumor growth (Fig. 7f).